BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

De Facto in MBO From Chime plc.


7/13/2012 7:51:32 AM

13th July, 2012 - London – De Facto Communications, the healthcare and life sciences Communications specialist, has completed a management buyout of the business from Chime Communications Plc. The new agency will be headed by a senior management team of Tristan Jervis and Alex Heeley, with 4 main divisions running across digital, branding and design, scientific writing and PR.

Initially the new business will be based at Chime’s Holborn Gate offices after the transaction was formally completed on 30th June 2012, and De Facto’s core client roster will be moving with the new management team.

Tristan Jervis, Managing Partner at De Facto, said: “With Chime and Bell Pottinger moving in separate directions, we felt this was the perfect time to refocus De Facto on its core healthcare and life sciences capabilities. Increasingly our clients are turning to us for a broader range of services in response to the need to communicate more widely with patients and consumers, in addition to traditional scientific, business and healthcare audiences. Moving forwards, we will be looking to grow organically and are particularly focused on helping companies we believe are contributing positively in the healthcare and life sciences arena both in Europe and the USA.”

“Our approach is to integrate a tailored mix of elements for each client starting with PR, and incorporating other disciplines as appropriate from creative design, market research, branding, stakeholder relations, but with digital forming an essential part of all client strategies. The best campaigns that resonate most effectively with audiences are greater than the sum of their parts and include a multiplatform dimension. In the future we will look to take a holistic view of the client’s overall business objectives before implementing a bespoke mix of elements to create the greatest noise and deliver work that retains its impact – designing campaigns around the point of interaction for our clients’ stakeholders.” Alex Heeley, Partner - Director of strategy

For more information, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 861 3838 or e-mail: t.jervis@defacto.com.

A non-disclosure agreement has been signed by both parties and no financial terms or further any contractual details can be disclosed at this point.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES